The pharmaceutical industry faces significant challenges in managing the lifecycle of drugs, particularly in the area of drug safety monitoring. Traditional methods of processing safety cases are reliable but time-consuming and labor-intensive, often taking up to a week to complete. This process
The ability to control matter at the atomic level with remarkable precision has long been a dream in the field of nanotechnology. Recent advancements led by physicists at the University of Bath, in collaboration with an international team, have brought us closer to this goal. This breakthrough
In an era where medical science continually evolves, two pivotal areas of study are presenting groundbreaking findings likely to shape future therapeutic approaches. These research subjects delve into herpes simplex virus (HSV) mutations contributing to drug resistance and the intricate role of
The realm of bioprinting has witnessed a momentous development thanks to a team of innovative researchers at Penn State University. This scientific group has pioneered an advanced bioprinting technique that employs spheroids—clusters of cells—to fabricate complex tissue with enhanced precision and
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Beckman Coulter Life Sciences, a subsidiary of Danaher Corporation, has announced the launch of the Cydem VT Automated Clone Screening System, an innovative platform designed to transform the world of drug discovery through advanced laboratory automation and innovation. This groundbreaking
